Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation

Bone Marrow Transplantation

Volumn 27, Issue 11, 2001, Pages 1173-1180

  Iguchi, A ^a,b   Kobayashi, R ^a   Yoshida, M ^a   Kobayashi, K ^a   Matsuo, K ^c   Kitajima, I ^b,d   Maruyama, I ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Base Technology Center   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Hepatic veno occlusive disease; Protein C; Stem cell transplantation; Vascular endothelial growth factor

Indexed keywords

ANTITHROMBIN III; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; CYTOKINE; ETOPOSIDE; MELPHALAN; METHOTREXATE; PLASMA PROTEIN; PROTEIN C; TACROLIMUS; THROMBOPLASTIN; THYMOCYTE ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BLOOD VESSEL PERMEABILITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CIRCULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DEATH; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERCOAGULABILITY; LIVER VENOOCCLUSIVE DISEASE; LYMPH NODE IRRADIATION; MACROPHAGE; MALE; MONOCYTE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; RHABDOMYOSARCOMA; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INFANT; LYMPHOKINES; MALE; PROGNOSIS; PROTEIN C; TIME FACTORS; TRANSPLANTATION CONDITIONING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034948615     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703061     Document Type: Article

References (31)

1. Venoocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors
2. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
3. Changes in natural anticoagulants following bone marrow transplantation
4. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers
5. Naturally occurring anticoagulants and bone marrow transplantation: Plasma protein C predicts the development of venocclusive disease of the liver
6. Rapid analysis of tumor necrosis factor-alpha mRNA expression during venocclusive disease of the liver after allogeneic bone marrow transplantation
7. High plasma levels of tumor necrosis factor-α may be predictive of veno-occlusive disease in bone marrow transplantation
8. Changes in plasma transforming growth factor beta in response to high-dose chemotherapy for stage II breast cancer: Possible implications for the prevention of hepatic veno-occlusive disease and pulmonary drug toxicity
9. The vascular endothelial growth factor family of polypeptides
10. Vascular endothelial growth factor is a secreted angiogenic mitogen
11. Purification of a glycoprotein vascular endothelial mitogen from a rat glioma cell line
12. Tumor vascular permeability factor stimulates endothelial growth and angiogenesis
13. Molecular and biological properties of the vascular endothelial growth factor family of proteins
14. Marrow transplantation for severe aplastic anemia: Methotrexate and cyclosporine for prevention of acute graft-versus-host disease
15. Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
16. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum
17. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome
18. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: Functional analysis of the tumor necrosis factor receptors
19. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation
20. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: A role for tissue factor gene expression
21. Human neutrophils secrete vascular endothelial growth factor
22. Intracellular pool of vascular endothelial growth factor in human neutrophils
23. Activated human neutrophils express vascular endothelial growth factor (VEGF)
24. Neurological complications after stem cell transplantation in childhood
25. Bacterial translocation from gut to portal blood as a factor of hypercoagulopathy in hepatic sinusoids after orthotopic liver transplantation in rats
26. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats
27. Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture
28. The mechanisms of hepatic sinusoidal cell regeneration: A possible communication system associated with vascular endothelial growth factor in liver cells
29. Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease
30. VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells
31. Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor